Acticor Biotech Logo

Acticor Biotech

Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.

ALACT | PA

Overview

Corporate Details

ISIN(s):
FR0012519668 (+1 more)
LEI:
969500K433EK1G89EV95
Country:
France
Address:
82 AVENUE DU MAINE, 75014 PARIS
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Acticor Biotech is a clinical-stage biopharmaceutical company, established as a spin-off from the French National Institute of Health and Medical Research (INSERM). The company is dedicated to developing innovative treatments for thrombotic diseases, with a primary focus on cardiovascular emergencies like acute ischemic stroke. Its lead product candidate, glenzocimab, is a 'first-in-class' drug designed to safely treat the acute phase of thrombotic events. Acticor Biotech has also explored the use of glenzocimab in other indications, such as acute respiratory distress syndrome (ARDS).

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-01-06 08:00
Legal Proceedings Report
Inside Information / Other news releases
English 171.0 KB
2025-01-06 08:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 169.3 KB
2024-12-19 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 205.7 KB
2024-12-19 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 214.6 KB
2024-12-10 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 202.1 KB
2024-12-10 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 214.1 KB
2024-11-06 08:30
Legal Proceedings Report
Inside Information / Other news releases
English 177.1 KB
2024-11-06 08:30
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 179.2 KB
2024-11-04 11:46
Earnings Release
Inside Information / News release on accounts, results
English 322.8 KB
2024-11-04 11:46
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 311.2 KB
2024-10-31 17:45
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 400.7 KB
2024-10-31 17:45
Interim Report
Inside Information / News release on accounts, results
English 464.4 KB
2024-10-16 17:45
Legal Proceedings Report
Inside Information / Other news releases
English 289.1 KB
2024-10-16 17:45
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 223.1 KB
2024-10-14 08:00
Board/Management Information
Informations privilégiées / Autres communiqués
French 275.7 KB

Automate Your Workflow. Get a real-time feed of all Acticor Biotech filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Acticor Biotech via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM
Adtraction Group AB Logo
A partner marketing platform driving online sales for brands with a performance-based model.
Sweden ADTR

Talk to a Data Expert

Have a question? We'll get back to you promptly.